Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
about
Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterizationBioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studiesNovel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced LipophilicityGlutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disordersPhenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II.Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?Synthesis and Biological Evaluation of Substrate-Based Imaging Agents for the Prostate-Specific Membrane Antigen.The folate hydrolase 1561C>T polymorphism is associated with depressive symptoms in Puerto Rican adults.N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophreniaLocalization of NAAG-related gene expression deficits to the anterior hippocampus in schizophreniaAltered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerNAAG, NMDA receptor and psychosisThe therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseFOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.
P2860
Q27653047-761F4346-6FB8-4D01-BFEF-83C5CC4B96CFQ27658096-849B5F88-B0F7-496C-A148-A4A078EBE4D0Q27674033-A4FFBB31-1BEA-42AB-B683-28E60863D42BQ30387014-9F3A60BB-C20D-4274-8EB9-4623598EB42FQ30453993-76CB4884-9A89-4CB7-B9DB-B548C1DDFAFFQ30480306-4A472635-96EA-440F-9DF2-B82589AE1FC1Q33812982-56C85F5B-A277-424A-939B-53D228997C80Q34344595-31271489-81D4-4A2C-A943-975D83797998Q35032387-29566B30-A106-4C31-840C-7B1438245198Q36471469-B0BAF8ED-028A-43F1-AC02-4619893E21A1Q37199826-53BA3450-03F3-408B-A2BB-C443A5E95FECQ37306496-87155990-4186-4368-B2D5-FB6EB5FFFE59Q37387700-5C756DD7-4EC7-4736-BF88-8545CEC11D88Q37972920-8A835D15-1265-418A-9A73-FC9CC86EB4ADQ37981289-98355045-2A98-4E86-82CA-2CF503F0C6B8Q38831232-BB141E99-F5C0-4E9E-8680-1C595A449E7DQ41976143-44FA9964-211D-4567-A527-C68084C78E2F
P2860
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@ast
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@en
type
label
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@ast
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@en
prefLabel
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@ast
Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
@en
P2093
P2860
P1476
Dysregulation of glutamate carboxypeptidase II in psychiatric disease
@en
P2093
Alan P Kozikowski
Brian S Caffo
Catherine A Foss
Jennifer L McGlothan
Martin G Pomper
Tomás R Guilarte
P2860
P304
P356
10.1016/J.SCHRES.2007.11.013
P407
P577
2008-01-10T00:00:00Z